Molecular mechanism of methotrexate action in inflammation. - Wikidata - awgldk - TriplyDB

Molecular mechanism of methotrexate action in inflammation.

Molecular mechanism of methotrexate action in inflammation.

http://www.wikidata.org/entity/Q35501813

about

A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.Review article: monitoring of immunomodulators in inflammatory bowel disease.Methods to avoid infections in patients with inflammatory bowel disease.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.Safety profile of methotrexate in inflammatory bowel disease.Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis New insights into the pathogenesis and management of steroid-resistant asthma.Use of methotrexate in the management of sight-threatening uveitis.Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity

P2860

Q21142769-96794D82-A069-45DD-ACC7-E4846781353F Q24567559-4D31673F-1A84-47BB-AC53-EA4B40F4EB62 Q33869850-4B67B0B0-9CE8-41B2-BFA1-14325DAF9B21 Q34727664-1F9A04AA-81D9-44F4-9B15-C2EEA4A0503B Q36041146-8E9AFA94-6B57-45D9-B31F-43D7BA9564B5 Q36171733-99303D60-737E-40C5-B634-9C6DAD8F5176 Q38238947-B7023494-0906-4A34-BB40-66AB76A9C1C7 Q38766862-CD79A609-6B19-4114-8D14-5A4ACB36A9A3 Q38909929-6FEBABA8-B0C7-492A-B991-75CEEE665906 Q41208644-C4E16DEB-62A4-4941-8DAE-B4EAE4A22848 Q41486524-65CDE7FB-2A03-4001-AAC4-59029FAC47BF Q43550379-22FCC6EF-FFB7-42A9-925B-5D148FB7C408 Q47134975-2046A9E9-0BC6-4D6D-B418-24910981E35C Q57892275-4D47FF95-4669-4D50-84D2-274CF155780A

P2860

Molecular mechanism of methotrexate action in inflammation.

http://www.wikidata.org/entity/Q35501813

description

1992 nî lūn-bûn

@nan

1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Molecular mechanism of methotrexate action in inflammation.

@ast

Molecular mechanism of methotrexate action in inflammation.

@en

type

label

Molecular mechanism of methotrexate action in inflammation.

@ast

Molecular mechanism of methotrexate action in inflammation.

@en

prefLabel

Molecular mechanism of methotrexate action in inflammation.

@ast

Molecular mechanism of methotrexate action in inflammation.

@en

P1433

Q35501813-D8CAD0D4-E928-4E93-AC23-9477633F9B01

P1476

Q35501813-8B1F868D-50E4-4989-BB65-2E81A87AC767

P2093

Q35501813-FDE1F849-BA78-434E-95D5-4434751B9338

P2860

Q35501813-147E9B8A-ACCD-4E06-B9DB-F754BB99B301

Q35501813-37CBA9B0-1878-4629-8368-2688ADA58D4B

Q35501813-4E2E2FF2-87EC-427D-9D24-C01253A3746B

Q35501813-8063B117-44F1-426D-8073-D25A20AB34FE

Q35501813-89456697-4087-4968-9920-91125ED9D9B5

Q35501813-91165ABB-B97C-427F-9732-92A37CFB6AC5

Q35501813-99E28570-AB2E-433A-9CC2-47054912226B

Q35501813-E0925054-3542-4C33-86B3-BFD80EC01C40

Q35501813-EB853CE4-B368-4037-A95C-89B8D890F700

Q35501813-EF88AFE5-E2BF-4BA1-A56B-6040DCE4B518

P2888

Q35501813-ABC2ADA5-67FB-4CFD-B830-5CEB4FCDF7CC

P304

Q35501813-FAD39B0C-CF94-42F0-9FEE-928CBA90109F

P31

Q35501813-0BDFC152-D9D5-4771-9A55-60854D428799

P356

Q35501813-4D55F6F0-0B2B-4181-B0F4-556ED677DB71

P433

Q35501813-F8DB4FBC-2A11-4C4D-96E6-7E53CC47D719

P478

Q35501813-9B870149-5266-471E-B7A6-A556AF83EA29

P577

Q35501813-AE078D2A-24FE-4CCD-A0C7-C56FCDECA61A

P698

Q35501813-613C2D4D-EF65-48DA-9E8D-A269581C10F8

P921

Q35501813-4739B7AF-5BA8-4C4C-8FFC-969F84BC2760

P356

P1433

P1476

Molecular mechanism of methotrexate action in inflammation.

@en

P2093

Cronstein BN

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3': 5'-adenosine monophosphate, and intracellular calcium.

Advances in drug therapy for inflammatory bowel disease.

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury.

Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization.

Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism.

Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes.

Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis.

Long-term methotrexate treatment in corticosteroid-dependent asthma.

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

P2888

P304

411-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF00918968

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1428120

http://www.w3.org/2001/XMLSchema#string

P921